SEC Form 4 · accession 0001127602-15-020304
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Jun 10, 2015
Accepted (ET)
Jun 11, 2015 · 8:44 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 10, 2015 | M | 2,211 | $63.22 | A | 2,451 | D | |
| Common StockF2 | Jun 10, 2015 | S | 300 | $177.45 | D | 2,151 | D | |
| Common Stock | Jun 10, 2015 | S | 100 | $178.48 | D | 2,051 | D | |
| Common StockF3 | Jun 10, 2015 | S | 511 | $179.5649 | D | 1,540 | D | |
| Common StockF4 | Jun 10, 2015 | S | 300 | $181.3317 | D | 1,240 | D | |
| Common StockF5 | Jun 10, 2015 | S | 700 | $182.48 | D | 540 | D | |
| Common StockF6 | Jun 10, 2015 | S | 300 | $183.11 | D | 240 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common Stock | holding | — | — | — | 625,031 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $63.22 | Jun 10, 2015 | M | 2,211 | D | Dec 31, 2010 | Dec 31, 2020 | Common Stock | 2,211 | 411,265 | D |
| Stock OptionsF7 | $113.08 | holding | — | — | — | Dec 31, 2013 | Dec 31, 2023 | Common Stock | 1,000,000 | 1,000,000 | I |
| Stock OptionsF7 | $129.49 | holding | — | — | — | Dec 31, 2014 | Dec 31, 2024 | Common Stock | 723,869 | 723,869 | I |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2This transaction was executed in multiple trades at prices ranging from $176.94 to $177.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $179.04 to $180.035. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $181.00 to $181.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $182.00 to $182.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $183.03 to $183.175. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This stock option was transferred to a trust beneficially owned by the reporting person on June 10, 2015.